Evaluation of Immunogenicity and Safety of VARIVAX™ New Seed Process (NSP) in Children (V210-063)
Clinical trial NCT02062502 · COMPLETED
Trial details
- NCT number
- NCT02062502
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-07
- Primary completion
- 2015-02-24
- Enrollment
- 611
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.